スポンサーリンク
Dept. Obst. Gynec., Sapporo Med. College | 論文
- Studies on Histopathological Prognostic Factors in Cervical Cancers
- Immunocytochemical Staining of Estrogen Receptor in Cases of Insufficient Cervical Mucus Secretion and Normal Cervical Mucus Secretion
- 56. Studies on Prostaglandin F_ Receptor in Human Corpus Luteum
- 293. Clinical and Pathological Studies on Highly Differentiated Adenocarcinoma of Cervix (So Called Adenoma Malignum)
- Establishment of a Cell Line Derived from Human Uterine Cervical Adenocarcinoma and the Sensitivity to Anticancer Drugs
- 417. Effect of Aminoglutethimide on Androstenedione Aromatase Activity in Human Uterine Myoma
- 152. Measurement of Estrogen as Prognostic Indicator of Threatened Abortion-A Study of E_3-16-G Production
- 37. Morphological Studies on Human Uterine Cancer Cells in vitro
- 145. Uterine Sarcomas : Clinicopathological Study
- 126. Study on CT Findings and Clinical Course of Stage III Cervical Cancer
- Conparative Study of Ultrasonography, X-CT and MRI in Diagnosis of Ovarian Tumor
- 42. Psychosomatic Studies during Labor : Mainly Electrophysiological Studies during Dilatation
- Study on the Mechanism of Fasting Therapy : Bodily Function
- 179. Identification of Lymphocytes in Human Endometrial Cancer Tissues: The Second Report, Espiceally T Cell and T Cell Subsets of the Benign and Cancer Lesion in the Same Uterus
- Correation of Prolactin (PRL) in Amniotic Fluid and Fetal Membrane Prostaglandin E_2 (PGE_2) on the Initiation of Labor
- 444. Psychosomatic Study of Gynecological Operation; Vaginal Total Hysterectomy, Oophorectomy and Tubotomy
- Identification of T Cell Subsets and Interleukin-2 Receptor Infiltrating Uterine Cervical Cancer Tissues and Regional Lymphnodes
- Identification of Transferrin Receptor Epidermal Growth Factor Receptor and S Phase Cells in Endometrial Cancer
- Localization of Estrogen Receptor and Epidermal Growth Factor Receptor in Human Endometrial Carcinoma Tissues with Immunohistochemical Staining
- Spontaneous Resumption of Ovulatory Menstrual Cycle Following a Delivery in Patients with Prolactinoma